<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34036253</PMID><DateRevised><Year>2023</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2589-5370</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><PubDate><Year>2021</Year><Month>Jun</Month></PubDate></JournalIssue><Title>EClinicalMedicine</Title><ISOAbbreviation>EClinicalMedicine</ISOAbbreviation></Journal><ArticleTitle>Characteristics and predictors of acute and chronic post-COVID syndrome: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>100899</StartPage><MedlinePgn>100899</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100899</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.eclinm.2021.100899</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">A significant proportion of individuals experience lingering and debilitating symptoms following acute COVID-19 infection. The National Institute for Health and Care Excellence (NICE) have coined the persistent cluster of symptoms as post-COVID syndrome. This has been further sub-categorised into acute post-COVID syndrome for symptoms persisting three weeks beyond initial infection and chronic post-COVID syndrome for symptoms persisting beyond twelve weeks. The aim of this review was to detail the prevalence of clinical features and identify potential predictors for acute and chronic post-COVID syndrome.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic literature search, with no language restrictions, was performed to identify studies detailing characteristics and outcomes related to survivorship of post-COVID syndrome. The last search was performed on 6 March 2021 and all pre-dating published articles included. A means of proportion meta-analysis was performed to quantify characteristics of acute and chronic post-COVID syndrome. Study quality was assessed with a specific risk of bias tool. PROSPERO Registration: CRD42020222855.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">A total of 43 studies met the eligibility criteria; of which, 38 allowed for meta-analysis. Fatigue and dyspnoea were the most prevalent symptoms in acute post-COVID (0&#xb7;37 and 0&#xb7;35) and fatigue and sleep disturbance in chronic post-COVID syndrome (0&#xb7;48 and 0&#xb7;44), respectively. The available evidence is generally of poor quality, with considerable risk of bias, and are of observational design.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">In conclusion, this review highlights that flaws in data capture and interpretation, noted in the uncertainty within our meta-analysis, affect the applicability of current knowledge. Policy makers and researchers must focus on understanding the impact of this condition on individuals and society with appropriate funding initiatives and global collaborative research.</AbstractText><CopyrightInformation>&#xa9; 2021 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Iqbal</LastName><ForeName>Fahad M</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>Department of Surgery and Cancer, Imperial College London, St Mary's Hospital, London W2 1NY, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Global Health Innovation, Faculty Building, South Kensington Campus, Kensington SW7 2AZ, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lam</LastName><ForeName>Kyle</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Surgery and Cancer, Imperial College London, St Mary's Hospital, London W2 1NY, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Global Health Innovation, Faculty Building, South Kensington Campus, Kensington SW7 2AZ, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sounderajah</LastName><ForeName>Viknesh</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Surgery and Cancer, Imperial College London, St Mary's Hospital, London W2 1NY, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Global Health Innovation, Faculty Building, South Kensington Campus, Kensington SW7 2AZ, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clarke</LastName><ForeName>Jonathan M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Institute of Global Health Innovation, Faculty Building, South Kensington Campus, Kensington SW7 2AZ, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>EPSRC Centre for Mathematics of Precision Healthcare, Imperial College London, London SW7 2AZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashrafian</LastName><ForeName>Hutan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Surgery and Cancer, Imperial College London, St Mary's Hospital, London W2 1NY, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Global Health Innovation, Faculty Building, South Kensington Campus, Kensington SW7 2AZ, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Darzi</LastName><ForeName>Ara</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgery and Cancer, Imperial College London, St Mary's Hospital, London W2 1NY, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Global Health Innovation, Faculty Building, South Kensington Campus, Kensington SW7 2AZ, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_18032</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EClinicalMedicine</MedlineTA><NlmUniqueID>101733727</NlmUniqueID><ISSNLinking>2589-5370</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Intern Emerg Med. 2022 Mar;17(2):583-586. doi: 10.1007/s11739-021-02850-5</RefSource><PMID Version="1">34637081</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Coronavirus</Keyword><Keyword MajorTopicYN="N">Long covid</Keyword><Keyword MajorTopicYN="N">Post covid syndrome</Keyword><Keyword MajorTopicYN="N">SARS-CoV 2</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword></KeywordList><CoiStatement>None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>26</Day><Hour>7</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>5</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34036253</ArticleId><ArticleId IdType="pmc">PMC8141371</ArticleId><ArticleId IdType="doi">10.1016/j.eclinm.2021.100899</ArticleId><ArticleId IdType="pii">S2589-5370(21)00179-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organisation. WHO Coronavirus Disease (COVID-19) Dashboard. 2020. https://covid19.who.int/?gclid=CjwKCAjw2Jb7BRBHEiwAXTR4jTyiJ83RwLwaLTHzkxD3tqRLxDjbB8GqAxU09OFw-RB3F3Q0P4URcRoC46sQAvD_BwE (accessed Sept 19, 2020).</Citation></Reference><Reference><Citation>Greenhalgh T, Knight M, A'Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370 doi: 10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabavi N. Long covid: How to define it and how to manage it. BMJ. 2020;370:m3489.</Citation><ArticleIdList><ArticleId IdType="pubmed">32895219</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics (ONS). Coronavirus (COVID-19) Infection Survey. 2020. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/coronaviruscovid19infectionsurveypilot/4december2020 (accessed Dec 23, 2020).</Citation></Reference><Reference><Citation>Updated estimates of the prevalence of long COVID symptoms - Office for National Statistics. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthandlifeexpectancies/adhocs/12788updatedestimatesoftheprevalenceoflongcovidsymptoms (accessed March 9, 2021).</Citation></Reference><Reference><Citation>Callard F, Perego E. How and why patients made Long Covid. Soc Sci Med. 2021;268</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>. Long COVID: let patients help define long-lasting COVID symptoms. Nature. 2020;586:170.</Citation><ArticleIdList><ArticleId IdType="pubmed">33029005</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwan NA. Track COVID-19 sickness, not just positive tests and deaths. Nature. 2020;584:170.</Citation><ArticleIdList><ArticleId IdType="pubmed">32782377</ArticleId></ArticleIdList></Reference><Reference><Citation>How long does COVID-19 last? https://covid.joinzoe.com/post/covid-long-term?fbclid=IwAR1RxIcmmdL-EFjh_aI- (accessed Dec 12, 2020).</Citation></Reference><Reference><Citation>Alwan NA. Surveillance is underestimating the burden of the COVID-19 pandemic. Lancet. 2020;396:e24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7836224</ArticleId><ArticleId IdType="pubmed">32861312</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal FM, Lam K, Sounderajah V, Elkin S, Ashrafian H, Darzi A. Understanding the survivorship burden of long COVID. EClinicalMedicine. 2021:33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7904277</ArticleId><ArticleId IdType="pubmed">33649741</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence. COVID-19 rapid guideline: managing the long-term effects of COVID-19. NICE guideline (NG188). 2020; published online Dec 18. https://www.nice.org.uk/guidance/ng188 (accessed Jan 29, 2021).</Citation></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8:336&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pubmed">20171303</ArticleId></ArticleIdList></Reference><Reference><Citation>Covidence systematic review software, Veritas Health Innovation, Melbourne, Australia. Available at https://www.covidence.org.</Citation></Reference><Reference><Citation>Hoy D, Brooks P, Woolf A. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012;65:934&#x2013;939.</Citation><ArticleIdList><ArticleId IdType="pubmed">22742910</ArticleId></ArticleIdList></Reference><Reference><Citation>Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36:1&#x2013;48.</Citation></Reference><Reference><Citation>Arora G, Bittner V. Chest pain characteristics and gender in the early diagnosis of acute myocardial infarction. Curr Cardiol Rep. 2015;17:5.</Citation><ArticleIdList><ArticleId IdType="pubmed">25618302</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol. 2020 doi: 10.1002/jmv.26368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2020 doi: 10.1016/j.cmi.2020.09.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollini M, Ciccarelli M, Cecconi M. Vasculitis changes in COVID-19 survivors with persistent symptoms: an [18F]FDG-PET/CT study. Eur J Nucl Med Mol Imaging. 2020 doi: 10.1007/s00259-020-05084-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-05084-3</ArticleId><ArticleId IdType="pmc">PMC7595761</ArticleId><ArticleId IdType="pubmed">33123760</ArticleId></ArticleIdList></Reference><Reference><Citation>Bongiovanni M, Vignati M, Giuliani G. The dilemma of COVID-19 recurrence after clinical recovery. J. Infect. 2020 doi: 10.1016/j.jinf.2020.08.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.019</ArticleId><ArticleId IdType="pmc">PMC7428731</ArticleId><ArticleId IdType="pubmed">32810521</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmani H, Davoudi-Monfared E, Nourian A. Comparing outcomes of hospitalized patients with moderate and severe COVID-19 following treatment with hydroxychloroquine plus atazanavir/ritonavir. DARU, J Pharm Sci. 2020 doi: 10.1007/s40199-020-00369-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40199-020-00369-2</ArticleId><ArticleId IdType="pmc">PMC7453126</ArticleId><ArticleId IdType="pubmed">32857301</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE. Long-COVID&#x2019;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2020 doi: 10.1136/thoraxjnl-2020-215818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs LG, Gourna Paleoudis E, Lesky-Di Bari D. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS One. 2020;15</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7732078</ArticleId><ArticleId IdType="pubmed">33306721</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D, Baumeister RF, Veilleux JC. Risk factors associated with mental illness in hospital discharged patients infected with COVID-19 in Wuhan, China. Psychiatry Res. 2020 doi: 10.1016/j.psychres.2020.113297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2020.113297</ArticleId><ArticleId IdType="pmc">PMC7355324</ArticleId><ArticleId IdType="pubmed">32707218</ArticleId></ArticleIdList></Reference><Reference><Citation>C. C-S, E. L, A. L Follow-up of adults with non-critical COVID-19 two months after symptoms&#x2019; onset. Clin Microbiol Infect. 2020 doi: 10.1016/j.cmi.2020.09.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Venturelli S, Benatti SV., Casati M. Surviving COVID-19 in Bergamo Province: a post-acute outpatient re-evaluation. Epidemiol Infect. 2021;149 doi: 10.1017/S0950268821000145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268821000145</ArticleId><ArticleId IdType="pmc">PMC7873454</ArticleId><ArticleId IdType="pubmed">33461632</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz Y, Van Herck M, Delbressine J. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson KB, Rao M, Bonilla H. Patients with uncomplicated COVID-19 have long-term persistent symptoms and functional impairment similar to patients with severe COVID-19: a cautionary tale during a global pandemic. Clin Infect Dis. 2021;ciab103 doi: 10.1093/cid/ciab103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab103</ArticleId><ArticleId IdType="pmc">PMC7929039</ArticleId><ArticleId IdType="pubmed">33624010</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavem K, Ghanima W, Olsen MK, Gilboe HM, Einvik G. Prevalence and determinants of fatigue after COVID-19 in non-hospitalized subjects: a population-based study. 2021. doi:10.3390/ijerph18042030.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7921928</ArticleId><ArticleId IdType="pubmed">33669714</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Cruz RF, Waller MD, Perrin F. Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia. ERJ Open Res. 2021;7:00655&#x2013;02020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7585700</ArticleId><ArticleId IdType="pubmed">33575312</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan KS, Zheng JP, Mok YW. SARS: prognosis, outcome and sequelae. Respirology. 2003;8:S36&#x2013;S40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7169213</ArticleId><ArticleId IdType="pubmed">15018132</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1265&#x2013;1273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Bektas A, Schurman SH, Franceschi C, Ferrucci L. A public health perspective of aging: do hyper-inflammatory syndromes such as COVID-19, SARS, ARDS, cytokine storm syndrome, and post-ICU syndrome accelerate short- and long-term inflammaging? Immun Ageing. 2020;17:23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7443812</ArticleId><ArticleId IdType="pubmed">32849908</ArticleId></ArticleIdList></Reference><Reference><Citation>Lutchmansingh DD, Knauert MP, DE Antin-Ozerkis. A clinic blueprint for post-COVID-19 RECOVERY: learning from the past, looking to the future. Chest. 2020 doi: 10.1016/j.chest.2020.10.067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2020.10.067</ArticleId><ArticleId IdType="pmc">PMC7641526</ArticleId><ArticleId IdType="pubmed">33159907</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal FM, Joshi M, Davies G, Khan S, Ashrafian H, Darzi A. Design of the pilot, proof of concept REMOTE-COVID trial: remote monitoring use in suspected cases of COVID-19 (SARS-CoV-2) Pilot Feasibility Stud. 2021;7:62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7933391</ArticleId><ArticleId IdType="pubmed">33673868</ArticleId></ArticleIdList></Reference><Reference><Citation>Vindrola-Padros C, Singh KE, Sidhu MS. Remote home monitoring (virtual wards) during the COVID-19 pandemic: a living systematic review. medRxiv. 2020 doi: 10.1101/2020.10.07.20208587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.07.20208587</ArticleId></ArticleIdList></Reference><Reference><Citation>Darzi A, Goddard A, Henderson K. Increasing recruitment into covid-19 trials. BMJ. 2021;372:n235.</Citation><ArticleIdList><ArticleId IdType="pubmed">33514589</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020 doi: 10.1016/j.jinf.2020.08.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Daynes E, Gerlis C, Briggs-Price S, Jones P, Singh SJ. COPD assessment test for the evaluation of COVID-19 symptoms. Thorax. 2020 doi: 10.1136/thoraxjnl-2020-215916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215916</ArticleId><ArticleId IdType="pubmed">33148809</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen MS, Kristiansen MF, Hanusson KD. Long COVID in the Faroe Islands - a longitudinal study among non-hospitalized patients. Clin Infect Dis. 2020 doi: 10.1093/cid/ciaa1792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1792</ArticleId><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Borst B, Peters JB, Brink M. Comprehensive health assessment three months after recovery from acute COVID-19. Clin Infect Dis. 2020 doi: 10.1093/cid/ciaa1750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1750</ArticleId><ArticleId IdType="pmc">PMC7717214</ArticleId><ArticleId IdType="pubmed">33220049</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingstone T, Taylor AK, O'Donnell CA, Atherton H, Blane DN, Chew-Graham CA. Finding the &#x2018;right&#x2019; GP: a qualitative study of the experiences of people with long-COVID. BJGP open. 2020 doi: 10.3399/bjgpopen20X101143.</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgpopen20X101143</ArticleId><ArticleId IdType="pmc">PMC7880173</ArticleId><ArticleId IdType="pubmed">33051223</ArticleId></ArticleIdList></Reference><Reference><Citation>SNOMED CT COVID-19 related content - announcements - SNOMED Confluence. https://confluence.ihtsdotools.org/display/snomed/SNOMED+CT+COVID-19+Related+Content (accessed March 12, 2021).</Citation></Reference><Reference><Citation>Arnold DT, Hamilton FW, Milne A. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax. 2020 doi: 10.1136/thoraxjnl-2020-216086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216086</ArticleId><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A, Bernabei R, Landi F. Group GAC-19 P-ACS. persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D, Zhang W, Pan F. The pulmonary sequalae in discharged patients with COVID-19: a short-term observational study. Respir Res. 2020 doi: 10.1186/s12931-020-01385-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-020-01385-1</ArticleId><ArticleId IdType="pmc">PMC7245637</ArticleId><ArticleId IdType="pubmed">32448391</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellaud C, Grandmaison G, Pham Huu Thien HP. Characteristics, comorbidities, 30-day outcome and in-hospital mortality of patients hospitalised with COVID-19 in a Swiss area - a retrospective cohort study. Swiss Med Wkly. 2020;150:w20314.</Citation><ArticleIdList><ArticleId IdType="pubmed">32662869</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosales-Castillo A, Garc&#xed;a de los R&#xed;os C, Mediavilla Garc&#xed;a JD. Persistent symptoms after acute COVID-19 infection: importance of follow-up. Med Clin. 2021;156:35&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833449</ArticleId><ArticleId IdType="pubmed">33521308</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T, Sahanic S, Pizzini A. Cardiopulmonary recovery after COVID-19 &#x2013; an observational prospective multi-center trial. Eur Respir J. 2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7736754</ArticleId><ArticleId IdType="pubmed">33303539</ArticleId></ArticleIdList></Reference><Reference><Citation>Taboada M, Moreno E, Cari&#xf1;ena A. Quality of life, functional status, and persistent symptoms after intensive care of COVID-19 patients. Br. J. Anaesth. 2021;126:e110&#x2013;e113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833644</ArticleId><ArticleId IdType="pubmed">33413976</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomasoni D, Bai F, Castoldi R. Anxiety and depression symptoms after virological clearance of COVID-19: a cross-sectional study in Milan, Italy. J Med Virol. 2020 doi: 10.1002/jmv.26459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26459</ArticleId><ArticleId IdType="pmc">PMC7461061</ArticleId><ArticleId IdType="pubmed">32841387</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Xu H, Jiang H. Clinical features and outcomes of discharged coronavirus disease 2019 patients: a prospective cohort study. QJM. 2020 doi: 10.1093/qjmed/hcaa178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcaa178</ArticleId><ArticleId IdType="pmc">PMC7313792</ArticleId><ArticleId IdType="pubmed">32442308</ArticleId></ArticleIdList></Reference><Reference><Citation>Blair PW, Brown DM, Jang M. The clinical course of COVID-19 in the outpatient setting: a prospective cohort study. Open Forum Infect Dis. 2021;8 doi: 10.1093/ofid/ofab007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab007</ArticleId><ArticleId IdType="pmc">PMC7881750</ArticleId><ArticleId IdType="pubmed">33614816</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P, Borsetto D, Fabbris C. Evolution of altered sense of smell or taste in patients with mildly symptomatic COVID-19. JAMA Otolaryngol Head Neck Surg. 2020 doi: 10.1001/jamaoto.2020.1379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoto.2020.1379</ArticleId><ArticleId IdType="pmc">PMC7333173</ArticleId><ArticleId IdType="pubmed">32614442</ArticleId></ArticleIdList></Reference><Reference><Citation>Brand&#xe3;o Neto D, Fornazieri MA, Dib C. Chemosensory Dysfunction in COVID-19: prevalences, recovery rates, and clinical associations on a large Brazilian Sample. Otolaryngol - Head Neck Surg. 2020 doi: 10.1177/0194599820954825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0194599820954825</ArticleId><ArticleId IdType="pmc">PMC7464054</ArticleId><ArticleId IdType="pubmed">32867582</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiesa-Estomba CM, Lechien JR, Radulesco T. Patterns of smell recovery in 751 patients affected by the COVID-19 outbreak. Eur J Neurol. 2020 doi: 10.1111/ene.14440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14440</ArticleId><ArticleId IdType="pmc">PMC7405216</ArticleId><ArticleId IdType="pubmed">32677329</ArticleId></ArticleIdList></Reference><Reference><Citation>Fjaeldstad AW. Prolonged complaints of chemosensory loss after COVID-19. Dan Med J. 2020;67(8)</Citation><ArticleIdList><ArticleId IdType="pubmed">32741438</ArticleId></ArticleIdList></Reference><Reference><Citation>Lovato A, Galletti C, Galletti B, de Filippis C. Clinical characteristics associated with persistent olfactory and taste alterations in COVID-19: a preliminary report on 121 patients. Am. J. Otolaryngol. - Head Neck Med. Surg. 2020 doi: 10.1016/j.amjoto.2020.102548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjoto.2020.102548</ArticleId><ArticleId IdType="pmc">PMC7250081</ArticleId><ArticleId IdType="pubmed">32516656</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaes AW, Machado FVC, Meys R. Care dependency in non-hospitalized patients with COVID-19. J Clin Med. 2020;9 doi: 10.3390/jcm9092946.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9092946</ArticleId><ArticleId IdType="pmc">PMC7564703</ArticleId><ArticleId IdType="pubmed">32932582</ArticleId></ArticleIdList></Reference><Reference><Citation>Villarreal IM, Morato M, Mart&#xed;nez-RuizCoello M. Olfactory and taste disorders in healthcare workers with COVID-19 infection. Eur Arch Oto-Rhino-Laryngology. 2020 doi: 10.1007/s00405-020-06237-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-06237-8</ArticleId><ArticleId IdType="pmc">PMC7385204</ArticleId><ArticleId IdType="pubmed">32725271</ArticleId></ArticleIdList></Reference><Reference><Citation>Darley DR, Dore GJ, Cysique L. Persistent symptoms up to four months after community and hospital-managed SARS-CoV-2 infection. Med J Aust. 2021 mja2.50963.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8014234</ArticleId><ArticleId IdType="pubmed">33657671</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins C, Surda P, Vaira LA. Six month follow-up of self-reported loss of smell during the COVID-19 pandemic. Rhinology. 2020;59(1):26&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">33320115</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam MS, Ferdous MZ, Islam US, Mosaddek ASM, Potenza MN, Pardhan S. Treatment, persistent symptoms, and depression in people infected with COVID-19 in Bangladesh. Int J Environ Res Public Health. 2021;18:1453.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7914967</ArticleId><ArticleId IdType="pubmed">33562427</ArticleId></ArticleIdList></Reference><Reference><Citation>Lampl BMJ, Buczovsky M, Martin G, Schmied H, Leitzmann M, Salzberger B. Clinical and epidemiological data of COVID-19 from Regensburg, Germany: a retrospective analysis of 1084 consecutive cases. Infection. 2021;1:3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7934115</ArticleId><ArticleId IdType="pubmed">33666894</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, De Lorenzo R, Conte C. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav Immun. 2020 doi: 10.1016/j.bbi.2020.07.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.07.037</ArticleId><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference><Reference><Citation>Poncet-Megemont L, Paris P, Tronchere A. High prevalence of headaches during Covid-19 infection: a retrospective cohort study. Headache. 2020 doi: 10.1111/head.13923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/head.13923</ArticleId><ArticleId IdType="pmc">PMC7436456</ArticleId><ArticleId IdType="pubmed">32757419</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dyer AH, Jones K. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One. 2020;15</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dowds J, O'Brien K. Persistent poor health post-COVID-19 is not associated with respiratory complications or initial disease severity. Ann Am Thorac Soc. 2021 doi: 10.1513/annalsats.202009-1175oc. published online Jan 8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/annalsats.202009-1175oc</ArticleId><ArticleId IdType="pmc">PMC8456724</ArticleId><ArticleId IdType="pubmed">33413026</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira LA, Hopkins C, Petrocelli M. Smell and taste recovery in coronavirus disease 2019 patients: A 60-day objective and prospective study. J Laryngol Otol. 2020 doi: 10.1017/S0022215120001826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0022215120001826</ArticleId><ArticleId IdType="pmc">PMC7471571</ArticleId><ArticleId IdType="pubmed">32782030</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>